2020
DOI: 10.1177/2047487320951109
|View full text |Cite
|
Sign up to set email alerts
|

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers

Abstract: Heart failure is a complex syndrome affecting several organs including kidney, lungs, liver, brain muscles and sympathetic system. Each of these organs might contribute to its severity and prognosis. The prognosis assessment is critical for a correct heart failure management. It has already been demonstrated that a single parameter is weaker for prognosis than different parameters combined. The Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score has been built and validated for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…Primarily, being a preliminary investigation into the relationship between CPET parameters and the severity of CAD, it included a small patient cohort, necessitating further validation of its findings in a broader real-world patient population. Additionally, the influence of beta blockers and other cardioprotective drugs on CPET results is significant, 32 suggesting their discontinuation before CPET could enhance protocol standardization in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…Primarily, being a preliminary investigation into the relationship between CPET parameters and the severity of CAD, it included a small patient cohort, necessitating further validation of its findings in a broader real-world patient population. Additionally, the influence of beta blockers and other cardioprotective drugs on CPET results is significant, 32 suggesting their discontinuation before CPET could enhance protocol standardization in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, further research in a larger cohort of patients with CAD is warranted to refine the diagnostic and prognostic potential of CPET. Beta blockers and other cardioprotective drugs significantly impact the CPET results and should be discontinued prior to CPET to improve the study’s protocol standardization [ 31 ]. There were also some limitations in assessing the severity of coronary artery disease and more accurate evaluation methods still need further exploration.…”
Section: Limitationsmentioning
confidence: 99%